Overland Park, KS-based ProPharma Group, a comprehensive compliance services company serving the pharmaceutical, biotechnology, and medical device industries, has acquired PROSAR, a provider of pharmacovigilance and medical information services. This acquisition brings PROSAR together with international medical information service provider, PI ARM, a wholly-owned subsidiary of ProPharma Group.
PROSAR is headquartered in St. Paul, MN, and provides global pharmacovigilance and medical information services throughout the U.S., Canada, Europe and other regions of the world. PI ARM currently provides global medical information services in approximately 30 different languages worldwide from its offices in Overland Park, KS, Richmond, England, and Melbourne, Australia.
The core services now provided through PROSAR and PI ARM include:
· Pharmacovigilance services for marketed and investigational products including assessment, MedDRA coding and narrative writing
· Round-the-clock medical information inquiry support in the Americas, Europe, Middle East, and Asia-Pacific
· 24/7 contact centers for intake of adverse events and product complaints
· Medical writing, including standard response letters, AMCP dossiers and aggregate safety reports
Following the acquisition, Steve Swantek, CEO of PROSAR, and Ann Claridge, COO of PROSAR, will continue as key leaders in the ProPharma Group organization. “We believe that integrating our global pharmacovigilance services with PI ARM’s global medical information services creates significant additional value for our clients,” said Steve Swantek.
Terms of the acquisition were not disclosed.